Transplant for Metabolic Disorders Stockton CA

U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb. The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

Carlos Enrique Meza, MD
(209) 939-3840
1805 N California St Ste 202
Stockton, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Univ Auto De Guadalajara, Fac De Med, Guadalajara, Jalisco, Mexico
Graduation Year: 1975

Data Provided by:
Dennis William Delpaine
(209) 951-4100
5309 Carrington Circle
Stockton, CA
Specialty
Allergy / Immunology

Data Provided by:
Peter F Kao
(209) 476-2000
7373 West Ln
Stockton, CA
Specialty
Allergy / Immunology

Data Provided by:
Michael Y.s. Wong
(209) 476-2000
7373 West Ln
Stockton, CA
Specialty
Allergy / Immunology

Data Provided by:
George William Bensch, MD
(209) 334-4002
999 S Fairmont Ave Ste 120
Lodi, CA
Specialties
Allergy & Immunology
Gender
Male
Languages
Spanish
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1968
Hospital
Hospital: San Joaquin Gen Hosp, French Camp, Ca; St Josephs Med Ctr, Stockton, Ca
Group Practice: Allergy Immunology & Asthma

Data Provided by:
Jerold Joseph Yecies, MD
(209) 951-5353
4628 Georgetown Pl
Stockton, CA
Specialties
Allergy & Immunology, Pulmonary Diseases
Gender
Male
Education
Medical School: Hahnemann Univ Sch Of Med, Philadelphia Pa 19102
Graduation Year: 1966
Hospital
Hospital: St Josephs Med Ctr, Stockton, Ca
Group Practice: Allergy Immunology & Asthma

Data Provided by:
James Jaing, MD
(209) 476-2162
7373 West Ln
Stockton, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Dennis William Del Paine, MD
(209) 951-4100
5309 Carrington Cir
Stockton, CA
Specialties
Allergy & Immunology, Rheumatology
Gender
Male
Education
Medical School: Univ Of Ca, Davis, Sch Of Med, Davis Ca 95616
Graduation Year: 1977
Hospital
Hospital: St Josephs Med Ctr, Stockton, Ca
Group Practice: Dennis W Del Paine Inc

Data Provided by:
David Allan Stadtner, MD
(209) 943-1510
500 W Hospital Rd
French Camp, CA
Specialties
Allergy & Immunology
Gender
Male
Education
Medical School: Washington Univ Sch Of Med, St Louis Mo 63110
Graduation Year: 1943

Data Provided by:
Gregory William Bensch, MD
(209) 823-1092
200 Cottage Ave Ste 104
Manteca, CA
Specialties
Allergy & Immunology, Internal Medicine
Gender
Male
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1994

Data Provided by:
Data Provided by:

Transplant for Metabolic Disorders

Provided By:

FRIDAY, Oct. 16 (HealthDay News) -- U.S. researchers are testing a new approach in cord-blood transplants to treat genetic metabolic disorders in babies while they're still in the womb.

The new method uses a small, select number of therapeutic stem cells that have been treated to speed and improve engraftment (acceptance of the transplant by the body), explained Dr. Joanne Kurtzberg, a professor of pediatrics and pathology and director of the pediatric blood and marrow transplant program at Duke University Medical Center in Durham, N.C.

She and her team are studying the new procedure in a pilot trial open to pregnant women at risk for having children with fatal metabolic disorders, including Krabbe disease, metachromatic leukodystrophy, Pelizaeus-Maerzbacher disease, Tay-Sachs disease and Sandoff disease.

If untreated, these metabolic disorders can lead to bone, brain and central nervous system problems, and early death, the study authors noted in a Duke news release.

Donor cells used in the study will be made by the biopharmaceutical company Aldagen, Inc, which is a partner in the trial.

In many cases, cord-blood transplants after birth have proven successful in treating inherited metabolic disorders. Transplant timing is critical, Kurtzberg stressed.

"The idea is to give the baby cord-blood stem cells from a healthy donor that have the potential to provide healthy genes that can replace the ones that aren't working properly in the baby's own cells," Kurtzberg said in the news release.

In general, the earlier the transplant, the more likely it will work. That means that performing the transplant before the baby is born is ideal, she explained.

During the procedure, donor cells are injected directly into the fetus's abdomen at 12 to 14 weeks' pregnancy. At birth, the baby will be tested to see if the donor cells are present, and if they're fixing the malfunctioning genes. If not, the baby would be eligible for conventional cord-blood stem cell transplant within a few weeks.

More information

The Nemours Foundation has more about metabolism and metabolic disorders.

SOURCE: Duke Medicine, news release, Oct. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com